Patents Assigned to Guizhou Liansheng Pharmaceutical Co. Ltd.
  • Medicaments for inhibiting thrombus formation
    Patent number: 8921390
    Abstract: A Medicaments for inhibiting thrombus formation contains active ingredients which are triflusal and clopidogrel bisulfate, wherein a mass ratio of triflusal to clopidogrel bisulfate is (100-650):(30-150), preferably (1-20):1, more preferably (3-6):1, and even more preferably 3:1 or 6:1.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: December 30, 2014
    Assignee: Guizhou Liansheng Pharmaceutical Co. Ltd.
    Inventor: Chunhua Su